{
  "timestamp": "2025-04-19 14:51:33",
  "phase": "Evolution",
  "round": 2,
  "elo_score": null,
  "content": "Inherited mutations in homologous recombination (HR) repair genes (e.g., BRCA1/2, RAD51C/D) lead to increased DSB accumulation, higher neoplasia risk, and characteristic patterns of genomic instability that can guide personalized treatment strategies.  \n*Supporting evidence:* BRCA1/2 mutations compromise HR, leading to genomic instability and breast/ovarian cancer [Roy 2012]. HR deficiency is a clinical biomarker for PARP inhibitor sensitivity [Lord 2017, Science].\n\n---"
}